treatment [ftcn]
Hypertension, mild [fndg]
study results [fndg]
Final [tmco]
Objective [inpr]
Six [qnco]
Antihypertensive [phsu]
interventions [hlca]
treatment [ftcn]
Hypertension, mild [fndg]
Design [acty]
Randomized Controlled Clinical Trial [resa]
DOUBLE BLIND [resa]
placebo [topp]
setting [ftcn]
Hypertension screening [topp]
treatment [ftcn]
centers [spco]
United States [geoa]
participants [popg]
hypertensive [fndg]
Men [popg]
Women [popg]
Aged [orga]
Diastolic blood pressure [clna]
mmHg [qnco]
intervention [hlca]
Sustained [ftcn]
Nutritional [qlco]
Advice [hlca]
participants [popg]
weight [orga]
Dietary sodium intake [fndg]
Alcohol intake [inbe]
Physical activity [dora]
participants [popg]
Take [hlca]
placebo [topp]
N NOS [aapp, imft]
Chlortalidone [orch, phsu]
N NOS [aapp, imft]
Acebutolol [orch, phsu]
N NOS [aapp, imft]
Doxazosin Mesylate [orch, phsu]
N NOS [aapp, imft]
Amlodipine Maleate [orch, phsu]
N NOS [aapp, imft]
Enalapril Maleate [aapp, phsu]
N NOS [aapp, imft]
Main [qlco]
Outcome Measures [qnco]
Blood Pressure [orgf]
Quality [qlco]
Life [idcn]
side effects [ftcn]
blood lipid [lipd]
Components [mnob]
Echocardiography [diap]
Electrocardiographic changes [fndg]
cardiovascular events [fndg]
Average [qnco]
Blood Pressure [orgf]
reductions [npop]
Six [qnco]
Group [idcn]
participants [popg]
Assigned [ftcn]
Drug [phsu]
treatment [ftcn]
placebo [topp]
mmHg [qnco]
Systolic blood pressure [clna]
mmHg [qnco]
Diastolic blood pressure [clna]
P NOS [aapp, imft]
participants [popg]
Assigned [ftcn]
placebo [topp]
participants [popg]
GIVEN [cnce]
Drug [phsu]
treatment [ftcn]
Continued [idcn]
Initial [tmco]
Medication [phsu]
Mono [popg]
therapy [ftcn]
Smaller [qlco]
Percentage [qnco]
participants [popg]
Assigned [ftcn]
Drug [phsu]
treatment [ftcn]
Group [idcn]
Died [orgf]
experience [menp]
Cardiovascular event [fndg]
Assigned [ftcn]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Including [ftcn]
Clinical Events [idcn]
Percentage [qnco]
participants [popg]
Affected [ftcn]
In [qnco]
Drug [phsu]
treatment [ftcn]
Group [idcn]
In [qnco]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Incidence Rate [qnco]
Resting [dora]
Electrocardiographic abnormalities [fndg]
Quality [qlco]
Life [idcn]
Improved [qlco]
Assigned [ftcn]
Drug [phsu]
treatment [ftcn]
Group [idcn]
placebo [topp]
Group [idcn]
Five [qnco]
Drug [phsu]
Treatments [topp]
FAVOR [orch, phsu, vita]
Group [idcn]
Regression [patf]
Left ventricular mass [fndg]
blood lipid [lipd]
Outcome Measures [qnco]
Conclusions [idcn]
Initial [tmco]
Regimen [topp]
Drug [phsu]
treatment [ftcn]
Combination [qlco]
Nutritional Intervention [topp]
effective [qlco]
PREVENT [phsu]
CARDIOVASCULAR [bdsy]
Clinical Events [idcn]
Nutritional [qlco]
treatment [ftcn]
Alone [qnco]
Drug [phsu]
treatment [ftcn]
Group [idcn]
Minimal [qlco]
Large [qnco]
Scale [medd]
Clinical Trials [resa]
Evaluate [ftcn]
Drug [phsu]
Treatments [topp]
cardiovascular events [fndg]
findings [ftcn]
Support [medd]
recommendations [idcn]
Fifth [qnco]
Joint [bsoj]
national [inpr]
Committee [grup]
Report [inpr]
treatment [ftcn]
choices [inbe]
People [popg]
Stage 1 [inpr]
Mild [qlco]
Hypertension [dsyn]
